Immunohistochemistry in Alzheimer’s disease: an essential tool for preclinical therapeutic evaluation and the transition toward digital histological analysis
Alzheimer’s disease (AD) is characterized by amyloid-β (Aβ) plaques, tau pathology, synaptic degeneration and neuroinflammation and its growing global prevalence underscores the